Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC71119 structure
    GC71119UBX1325
    CAS: 2271269-01-1
    纯度: >98.00%

    UBX1325是一种促进衰老细胞凋亡的Bcl-xL抑制剂。

  • GC71128 structure
    GC71128Diclofenac-d4 sodium
    CAS: 154523-54-3
    纯度: >99.00%

    Diclofenac-d4 sodium是氘标记的双氯芬酸钠。

  • GC71180 structure
    GC71180SZM679
    CAS: 3027645-52-6
    纯度: >99.00%

    SZM679是一种强效、口服活性和选择性的RIPK1抑制剂,RIPK1和RIPK3的Kd值分别为8.6 nM和>5000 nM。

  • GC71214 structure
    GC71214CZL55
    CAS: 667408-87-9
    纯度: >98.00%

    CZL55是一种半胱天冬酶-1抑制剂,IC50值为24nM。

  • GC71232 structure
    GC71232I-152
    CAS: 311343-11-0
    纯度: >98.00%

    I-152是含有n -乙酰半胱氨酸(NAC)和半胱胺(MEA)的缀合物。

  • GC71258 structure
    GC71258ASK1-IN-4
    CAS: 1427538-26-8
    纯度: 不显示

    ASK1-IN-4(化合物17)是ASK1抑制剂(IC50=0.2μM)。

  • GC71298 structure
    GC71298DRI-C21041 (DIEA)
    纯度: 不显示

    DRI-C21041 (DIEA)是CD40/CD40L相互作用抑制剂,IC50为0.31 μM。

  • GC71355 structure
    GC71355Zharp2-1
    CAS: 2772600-18-5
    纯度: >99.00%

    Zharp2-1是一种口服有效的RIPK2抑制剂,与炎症性肠病(IBD)高度相关。

  • GC71380 structure
    GC71380UCB-6876
    CAS: 637324-45-9
    纯度: >99.00%

    UCB-6876是一种TNFα抑制剂,与TNF三聚体的不对称晶体形式(KD = 22 μM)结合。

  • GC71507 structure
    GC715075'-Methylthioadenosine-13C6
    CAS: 2421187-73-5
    纯度: 不显示

    5'-Methylthioadenosine-13C6是13C标记的5'-甲硫腺苷。

  • GC71541 structure
    GC71541BMS-561392 formate
    CAS: 2922280-85-9
    纯度: 不显示

    BMS-561392 formate是BMS-561392的甲酸盐形式。

  • GC71544 structure
    GC71544Antroquinonol
    CAS: 1010081-09-0
    纯度: >98.00%

    Antroquinonol((+)-Antroquinonol),一种从蘑菇Antrodia camphorata中提取的泛醌衍生物,具有保肝、抗炎和抗癌作用。

  • GC71607 structure
    GC71607Melatonin-d7
    CAS: 615251-68-8
    纯度: >98.00%

    Melatonin-d7是氘标记的褪黑素。

  • GC71617 structure
    GC71617L-Ascorbic acid-13C-2
    CAS: 1313730-17-4
    纯度: >95.00%

    L-Ascorbic acid-13C-2是13C标记的L-抗坏血酸。

  • GC71622 structure
    GC71622Prednisone-d8
    纯度: 不显示

    Prednisone-d8是氘标记的泼尼松。

  • GC71624 structure
    GC71624Ketoprofen-d4
    CAS: 1219805-29-4
    纯度: >98.00%

    Ketoprofen-d4是氘标记的酮洛芬。

  • GC71632 structure
    GC71632Meloxicam-d3-1
    CAS: 1227358-55-5
    纯度: >98.00%

    Meloxicam-d3-1是氘标记的美洛昔康。

  • GC71833 structure
    GC718335-Aminolevulinic acid-d2 hydrochloride
    CAS: 187237-35-0
    纯度: >91.00%

    5-Aminolevulinic acid-d2 hydrochloride是氘标记的5-氨基酮戊酸盐酸盐。

  • GC71915 structure
    GC71915Tanshinone IIB
    CAS: 17397-93-2
    纯度: >99.00%

    Tanshinone IIB是丹参的主要活性成分,在亚洲国家被广泛用于中风和冠心病的研究。

  • GC71968 structure
    GC71968Celosin K
    CAS: 1950579-53-9
    纯度: >99.00%

    Celosin K(化合物8)可以从青藤种子中分离出来。

  • GC72001 structure
    GC72001Phellamurin
    CAS: 52589-11-4
    纯度: 不显示

    Phellamurin是从黄柏叶中提取的一种植物黄酮类苷,具有抑制肠道p -糖蛋白的作用。

  • GC72012 structure
    GC72012Dehydrocrenatidine
    CAS: 65236-62-6
    纯度: >98.00%

    Dehydrocrenatidine是一种天然生物碱,是一种特定的JAK抑制剂。

  • GC72018 structure
    GC72018Goniothalamin
    CAS: 17303-67-2
    纯度: >98.00%

    Goniothalamin(GTN)是一种具有抗癌、抗炎和免疫抑制特性的苯乙烯基内酯。

  • GC72054 structure
    GC72054Obovatol
    CAS: 83864-78-2
    纯度: >99.00%

    Obovatol是一种从厚朴叶中分离出来的联苯醚木脂素。